Eupraxia Pharmaceuticals Inc.

Toronto Stock Exchange:EPRX.TO

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

Location

Canada

Market Cap

USD 194.50 M

Share Price

USD 5.43

Avg Daily Volume

36,993

Change (1 day)

1.57%

Change (1 year)

101.63%

Change (YTD)

73.11%

Eupraxia Pharmaceuticals Inc. Total Liabilities for the year ending December 31, 2021: USD 9.23 M

Eupraxia Pharmaceuticals Inc. Total Liabilities is USD 9.23 M for the year ending December 31, 2021. Total liabilities are the total amount of a company's debts and other obligations.

Competitors

AbbVie Inc.

USD 190.58

ABBV

+4.19 2.25%

Novo Nordisk A/S

USD 67.42

NOVO-B.CO

+0.26 0.39%

Roche Holding AG

USD 338.90

RO.SW

+1.87 0.56%

Novartis AG

USD 118.69

NOVN.SW

-0.95 -0.80%

Abbott Laboratories

USD 131.74

ABT

+0.25 0.19%

AstraZeneca PLC

USD 140.04

AZN.L

-0.39 -0.28%

Merck & Co., Inc.

USD 82.43

MRK

+0.91 1.12%

Thermo Fisher Scientific Inc.

USD 416.31

TMO

-1.68 -0.40%

Amgen Inc.

USD 299.02

AMGN

+6.51 2.23%

Boston Scientific Corporation

USD 103.19

BSX

-0.29 -0.28%

Pfizer Inc.

USD 24.61

PFE

0.00%

Gilead Sciences, Inc.

USD 109.85

GILD

+0.79 0.72%

Vertex Pharmaceuticals Incorporated

USD 469.55

VRTX

+5.35 1.15%

Sanofi

USD 96.84

SAN.PA

+0.90 0.94%

Bristol-Myers Squibb Company

USD 47.17

BMY

+0.74 1.59%

CSL Limited

USD 160.99

CSL.AX

-0.54 -0.33%

GSK plc

USD 19.08

GSK.L

+0.31 1.65%

Chugai Pharmaceutical Co., Ltd.

USD 46.49

4519.T

+0.50 1.10%

Siemens Healthineers AG

USD 53.67

SHL.DE

+0.10 0.18%

Regeneron Pharmaceuticals, Inc.

USD 547.93

REGN

-0.03 -0.01%

Key Data

Date	Total Liabilities	Shareholders' Equity	Cash and Short-Term Investments	Receivables